Bio-relevant cobalt(II) complexes with compartmental polyquinoline ligand: Synthesis, crystal structures and biological activities
Bio-relevant cobalt(II) complexes with compartmental polyquinoline ligand: Synthesis, crystal structures and biological activities
复制标题
具有隔室聚喹啉配体的生物相关钴(II)配合物:合成、晶体结构和生物活性
DOI:
10.1016/j.jinorgbio.2014.11.003
复制
发表时间:
2015
影响因子:
3.9
通讯作者:
Yan Shi-Ping
中科院分区:
文献类型:
--
作者:
Li Jun-Ling;Jiang Lin;Wang Bi-Wei;Tian Jin-Lei;Gu Wen;Liu Xin;Yan Shi-Ping
Three new Co(II) complexes, [Co4(L)2(μ3-CrO4)2](ClO4)2· 2CH3CN (1), [Co2(L)(μ2-na)(H2O)](ClO4)2(2) and [Co2(L)(μ2-ba)](ClO4)2· 0.5CH3CN (3) (Hna = nicotinic acid, Hba = benzoic acid, HL=N,N,N′,N′-tetrakis (2-quinolylmethyl)-1,3-diaminopropan-2-ol), have been synthesized and characterized by various physicochemical techniques. The Co(II) centers are connected by endogenous alkoxy bridge fromL−and various extrinsic auxiliary linkers, some of which display coordination number asymmetry (5, 6-coordinated for1and2; 5, 5-coordinated for3). It is worth mentioning that complex1contains two rare reportedμ3-η1,η1,η1-CrO42−moieties. Susceptibility data of three complexes indicated intramolecular antiferromagnetic coupling of high-spin Co(II) atoms with exchange integral values (J) − 14.94 cm− 1, − 11.26 cm− 1and − 13.66 cm− 1for1,2and3, respectively. Interaction of compounds with calf thymus DNA (CT-DNA) have been investigated by absorption spectral titration, ethidium bromide (EB) displacement assay and viscosity measurement, which revealed that compounds bound to CT-DNA with a moderate intercalative mode, accompanied the affinities order:1>2≈3. Three complexes exhibit oxidative cleavage of pBR322 plasmid DNA including a reliance on H2O2as the activator. Compound1demonstrates an increased DNA cleavage activity as compared with2and3, which could degrade super coiled DNA (SC DNA) into nicked coiled DNA (NC DNA) in lower concentration (5 μM). Moreover, all compounds could quench the intrinsic fluorescence of bovine serum albumin (BSA) in a static quenching process. Complex1also shows higher anticancer activity than cisplatin with lower IC50value of incubation for both 24 h and 48 h.